Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences BioMEMS, Microfluidics & Biofabrication: Technologies and Applications

Rong Fan's Biography



Rong Fan, Harold Hodgkinson Professor of Biomedical Engineering, Yale University

Dr. Rong Fan is the Harold Hodgkinson Professor of Biomedical Engineering at Yale University and Professor of Pathology at Yale School of Medicine. He received a Ph.D. in Chemistry from the University of California at Berkeley and completed the postdoctoral training at California Institute of Technology before joining the faculty at Yale University in 2010. His current interest is focused on developing microtechnologies for single-cell and spatial omics profiling to interrogate functional cellular heterogeneity and inter-cellular signaling network in human health and disease (e.g., cancer and autoimmunity). He co-founded IsoPlexis, Singleron Biotechnologies, and AtlasXomics. He served on the Scientific Advisory Board of Bio-Techne. He is the recipient of a number of awards including the National Cancer Institute’s Howard Temin Career Transition Award, the NSF CAREER Award, and the Packard Fellowship for Science and Engineering. He has been elected to the American Institute for Medical and Biological Engineering (AIMBE), the Connecticut Academy of Science and Engineering (CASE), and the National Academy of Inventors (NAI).

Rong Fan Image

Single-Cell Functional Proteomics: Small Devices for Big Impact

Thursday, 16 March 2017 at 14:30

Add to Calendar ▼2017-03-16 14:30:002017-03-16 15:30:00Europe/LondonSingle-Cell Functional Proteomics: Small Devices for Big ImpactSELECTBIOenquiries@selectbiosciences.com

Dr. Fan will discuss novel technologies for single-cell proteomic profiling, in particular, a microchip technology for co-detection of 40+ functional proteins such as cytokines/chemokines at the level of single cells, representing the highest multiplexing recorded to date for a single-cell protein secretion function assay. This technology permits the full-spectrum dissection of anti-tumor T cell functions, correlating to clinical outcomes and potentially predicting therapeutic efficacy and toxicity.  Applying this technology to leukemic cells from patients identified the existence of polyfunctional cell populations associated with pathogenesis and therapeutic response. All these underscore the importance of measuring functional proteomic heterogeneity even in phenotypically identical cell populations in order to evaluate the quality of cell-based therapeutics or to monitor patient responses for precision medicine.


Add to Calendar ▼2017-03-16 00:00:002017-03-17 00:00:00Europe/LondonBioMEMS, Microfluidics and Biofabrication: Technologies and ApplicationsSELECTBIOenquiries@selectbiosciences.com